Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913478568> ?p ?o ?g. }
- W2913478568 endingPage "8" @default.
- W2913478568 startingPage "1" @default.
- W2913478568 abstract "Infection with Middle East respiratory syndrome coronavirus (MERS-CoV) could be asymptomatic or cause mild influenza-like illness. Therefore, the prevalence of MERS-CoV infections in the general population could be underestimated, which necessitates active surveillance to determine the epidemiological importance of asymptomatic cases. The aim of this study is to evaluate the performance of various serological assays and to estimate the seroprevalence of anti-MERS-CoV antibodies in high- and low-risk groups in Qatar. A total of 4858 samples were screened, including 4719 samples collected from healthy blood donors (BD) over a period of five years (2012-2016), 135 samples from baseline case contacts (CC) collected from individuals in close contact with three positive PCR-confirmed patients (CP), and four samples from MERS-CoV CP. Initial screening using anti-MERS-CoV IgG (IgG rS1-ELISA kit) revealed ten reactive samples from BD (10/4719, 0.21%), one from CC (1/135, 0.74%), and three from CP (3/4, 75%). Samples from CP but not from BD were also reactive by whole-virus anti-MERS-CoV IgG (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M1><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>3</mml:mn><mml:mo>/</mml:mo><mml:mn>4</mml:mn></mml:math>) and IgM (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M2><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>4</mml:mn></mml:math>) indirect immunefluorescent tests (IIFT) and pseudoparticle neutralization test (ppNT). The reactive sample from CC was also confirmed by ppNT. Surprisingly, one out of thirteen (7.7%) randomly selected IgG rS1-ELISA-negative BD samples from the initial screening was reactive by the IgM-IIFT (but not by the IgG-IIFT) and was subsequently confirmed by ppNT. All IgG rS1-ELISA-reactive samples from BD exhibited considerable reactivity to the four circulating human coronaviruses (HKU1, OC43, 229E, and NL63). Cross-reactivity with SARS was only reported for samples from CP using IgG and IgM-IIFT. In conclusion, we report a low prevalence of anti-MERS antibodies in the general population, which coincides with the low number of all reported cases by the time of our study (2017) in Qatar (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M3><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>21</mml:mn></mml:math>). The false-positive results and the observed cross-reactivity between MERS-CoV and other circulating human coronavirus necessitate more detailed evaluation of available serological assays." @default.
- W2913478568 created "2019-02-21" @default.
- W2913478568 creator A5012557095 @default.
- W2913478568 creator A5014505612 @default.
- W2913478568 creator A5016520050 @default.
- W2913478568 creator A5021608465 @default.
- W2913478568 creator A5029565170 @default.
- W2913478568 creator A5029892870 @default.
- W2913478568 creator A5041846756 @default.
- W2913478568 creator A5048641075 @default.
- W2913478568 creator A5049179565 @default.
- W2913478568 creator A5072815848 @default.
- W2913478568 creator A5078691598 @default.
- W2913478568 date "2019-02-18" @default.
- W2913478568 modified "2023-10-15" @default.
- W2913478568 title "Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in Qatar" @default.
- W2913478568 cites W115624668 @default.
- W2913478568 cites W1527662113 @default.
- W2913478568 cites W1592164749 @default.
- W2913478568 cites W1703839189 @default.
- W2913478568 cites W1852588318 @default.
- W2913478568 cites W1971690804 @default.
- W2913478568 cites W2025350760 @default.
- W2913478568 cites W2099941783 @default.
- W2913478568 cites W2100790445 @default.
- W2913478568 cites W2108756402 @default.
- W2913478568 cites W2117725678 @default.
- W2913478568 cites W2127814650 @default.
- W2913478568 cites W2145441153 @default.
- W2913478568 cites W2270879391 @default.
- W2913478568 cites W2271364844 @default.
- W2913478568 cites W2292700442 @default.
- W2913478568 cites W2396314265 @default.
- W2913478568 cites W2565003136 @default.
- W2913478568 cites W2604472481 @default.
- W2913478568 cites W2606148195 @default.
- W2913478568 cites W2612594162 @default.
- W2913478568 cites W2619554392 @default.
- W2913478568 cites W2624490324 @default.
- W2913478568 cites W2689849623 @default.
- W2913478568 cites W2735956566 @default.
- W2913478568 cites W2747964440 @default.
- W2913478568 cites W2750464792 @default.
- W2913478568 cites W2766054311 @default.
- W2913478568 cites W2774183946 @default.
- W2913478568 cites W2801316696 @default.
- W2913478568 cites W2886321229 @default.
- W2913478568 cites W3000580234 @default.
- W2913478568 cites W4210821905 @default.
- W2913478568 doi "https://doi.org/10.1155/2019/1386740" @default.
- W2913478568 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6398027" @default.
- W2913478568 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30906787" @default.
- W2913478568 hasPublicationYear "2019" @default.
- W2913478568 type Work @default.
- W2913478568 sameAs 2913478568 @default.
- W2913478568 citedByCount "33" @default.
- W2913478568 countsByYear W29134785682019 @default.
- W2913478568 countsByYear W29134785682020 @default.
- W2913478568 countsByYear W29134785682021 @default.
- W2913478568 countsByYear W29134785682022 @default.
- W2913478568 crossrefType "journal-article" @default.
- W2913478568 hasAuthorship W2913478568A5012557095 @default.
- W2913478568 hasAuthorship W2913478568A5014505612 @default.
- W2913478568 hasAuthorship W2913478568A5016520050 @default.
- W2913478568 hasAuthorship W2913478568A5021608465 @default.
- W2913478568 hasAuthorship W2913478568A5029565170 @default.
- W2913478568 hasAuthorship W2913478568A5029892870 @default.
- W2913478568 hasAuthorship W2913478568A5041846756 @default.
- W2913478568 hasAuthorship W2913478568A5048641075 @default.
- W2913478568 hasAuthorship W2913478568A5049179565 @default.
- W2913478568 hasAuthorship W2913478568A5072815848 @default.
- W2913478568 hasAuthorship W2913478568A5078691598 @default.
- W2913478568 hasBestOaLocation W29134785681 @default.
- W2913478568 hasConcept C126322002 @default.
- W2913478568 hasConcept C159654299 @default.
- W2913478568 hasConcept C203014093 @default.
- W2913478568 hasConcept C2777910003 @default.
- W2913478568 hasConcept C2778494684 @default.
- W2913478568 hasConcept C2908647359 @default.
- W2913478568 hasConcept C45189115 @default.
- W2913478568 hasConcept C71924100 @default.
- W2913478568 hasConcept C99454951 @default.
- W2913478568 hasConceptScore W2913478568C126322002 @default.
- W2913478568 hasConceptScore W2913478568C159654299 @default.
- W2913478568 hasConceptScore W2913478568C203014093 @default.
- W2913478568 hasConceptScore W2913478568C2777910003 @default.
- W2913478568 hasConceptScore W2913478568C2778494684 @default.
- W2913478568 hasConceptScore W2913478568C2908647359 @default.
- W2913478568 hasConceptScore W2913478568C45189115 @default.
- W2913478568 hasConceptScore W2913478568C71924100 @default.
- W2913478568 hasConceptScore W2913478568C99454951 @default.
- W2913478568 hasFunder F4320322472 @default.
- W2913478568 hasLocation W29134785681 @default.
- W2913478568 hasLocation W29134785682 @default.
- W2913478568 hasLocation W29134785683 @default.
- W2913478568 hasLocation W29134785684 @default.
- W2913478568 hasLocation W29134785685 @default.
- W2913478568 hasOpenAccess W2913478568 @default.